869997-00-2 Usage
Derivative of imidazole-4-carboxylic acid
The compound is a modification of the parent molecule imidazole-4-carboxylic acid.
Ester
The compound is formed by the reaction of an acid with an alcohol, resulting in an ester functional group.
Aromatic rings
The compound contains a 2-methylphenyl group and a 2-phenylethyl group, both of which are aromatic rings with substituents.
Solubility in organic solvents
The presence of aromatic groups suggests that the compound may have some degree of solubility in organic solvents.
Potential applications in pharmaceutical or agrochemical industries
Due to its unique structure and functional groups, the compound may have potential uses as a building block for more complex molecules in the pharmaceutical or agrochemical industries.
Check Digit Verification of cas no
The CAS Registry Mumber 869997-00-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,9,9,9 and 7 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 869997-00:
(8*8)+(7*6)+(6*9)+(5*9)+(4*9)+(3*7)+(2*0)+(1*0)=262
262 % 10 = 2
So 869997-00-2 is a valid CAS Registry Number.
869997-00-2Relevant academic research and scientific papers
Optimization of the in vitro and in vivo properties of a novel series of 2,4,5-trisubstituted imidazoles as potent cholecystokinin-2 (CCK2) antagonists
Buck, Ildiko M.,Black, James W.,Cooke, Tracey,Dunstone, David J.,Gaffen, John D.,Griffin, Eric P.,Harper, Elaine A.,Hull, Robert A. D.,Kalindjian, S. Barret,Lilley, Elliot J.,Linney, Ian D.,Low, Caroline M. R.,McDonald, Iain M.,Pether, Michael J.,Roberts, Sonia P.,Shankley, Nigel P.,Shaxted, Mark E.,Steel, Katherine I. M.,Sykes, David A.,Tozer, Matthew J.,Watt, Gillian F.,Walker, Martin K.,Wright, Laurence,Wright, Paul T.
, p. 6803 - 6812 (2007/10/03)
The systematic optimization of the structure of a novel 2,4,5-trisubstituted imidazole-based cholecystokinin-2 (CCK2) receptor antagonist afforded analogues with nanomolar receptor affinity. These compounds were now comparable in their potency
